On August 19, 2025, Oramed Pharmaceuticals Inc. held its annual meeting where stockholders approved an amendment increasing shares in the 2019 Stock Incentive Plan from 7.5 million to 9.5 million and re-elected directors. The sentiment is neutral, and the event is significant for the company's equity investors.